Codexis, Inc.
Veridion Score
Composite trend over time
Why is CDXS moving today?
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for CDXS.
CDXS insider activity
Codexis, Inc.
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for CDXS.
CDXS contract awards, year to date.
Public federal awards linked to this ticker.
CDXS lobbying filings, year to date.
Registered lobbying filings matched to Codexis, Inc..